Circadian disruption and cancer risk: A new concept of stromal niche (Review)

Izumi,Hiroto; Wang,Keyong; Morimoto,Yasuo; Sasaguri,Yasuyuki; Kohno,Kimitoshi

doi:10.3892/ijo.2013.2201

Circadian disruption and cancer risk: A new concept of stromal niche (Review)

Authors:
- Hiroto Izumi
- Keyong Wang
- Yasuo Morimoto
- Yasuyuki Sasaguri
- Kimitoshi Kohno
View Affiliations

Affiliations: Department of Occupational Pneumology, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan, Bio-information Research Center, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan, Center for Promotion of Clinical and Translational Research, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan, The President Laboratory, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
Published online on: November 29, 2013 https://doi.org/10.3892/ijo.2013.2201
Pages: 364-370

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Circadian rhythms regulate a variety of physiological functions. Epidemiological evidence indicates that disruption of these circadian rhythms might be linked to cancer. In general, imbalances in homeostasis, such as immune and hormonal dysfunctions, are thought to be involved in cancer development. The results of a recent study suggested that circadian disruption may induce stromal changes associated with cancer risk, highlighting the importance of the cancer stem cell niche for protecting cancer cells. Current research provides new concepts and clarification regarding the function of the tumor niche, and the new concept of a stromal niche may help us to understand the additional functions of both cancer-associated fibroblasts and the extracellular matrix. In this review, we summarize our current knowledge regarding the role of circadian rhythms in cancer risk and the relevance of the stromal niche in cancer cell survival and progression.

View Figures

View References

1.	Antoni MH, Lutgendorf SK, Cole SW, et al: The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 6:240–248. 2006. View Article : Google Scholar : PubMed/NCBI
2.	Lutgendorf SK, Sood AK and Antoni MH: Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol. 28:4094–4099. 2010. View Article : Google Scholar : PubMed/NCBI
3.	Costa G, Haus E and Stevens R: Shift work and cancer-considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health. 36:163–179. 2010. View Article : Google Scholar : PubMed/NCBI
4.	Kolstad HA: Nightshift work and risk of breast cancer and other cancers - a critical review of the epidemiologic evidence. Scand J Work Environ Health. 34:5–22. 2008. View Article : Google Scholar : PubMed/NCBI
5.	McGregor BA and Antoni MH: Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators. Brain Behav Immun. 23:159–166. 2009. View Article : Google Scholar : PubMed/NCBI
6.	Fu L and Lee CC: The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 3:350–361. 2003. View Article : Google Scholar : PubMed/NCBI
7.	Yu EA and Weaver DR: Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany, NY). 3:479–493. 2011.PubMed/NCBI
8.	Borovski T, De Sousa E, Melo F, Vermeulen L and Medema JP: Cancer stem cell niche: the place to be. Cancer Res. 71:634–639. 2011. View Article : Google Scholar : PubMed/NCBI
9.	Li L and Xie T: Stem cell niche: structure and function. Annu Rev Cell Dev Biol. 21:605–631. 2005. View Article : Google Scholar : PubMed/NCBI
10.	McAllister SS and Weinberg RA: Tumor-host interactions: a far-reaching relationship. J Clin Oncol. 28:4022–4028. 2010. View Article : Google Scholar : PubMed/NCBI
11.	Lu P, Weaver VM and Werb Z: The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
12.	Provenzano PP, Inman DR, Eliceiri KW, et al: Collagen density promotes mammary tumor initiation and progression. BMC Med. 6:112008. View Article : Google Scholar : PubMed/NCBI
13.	Coghlin C and Murray GI: Current and emerging concepts in tumour metastasis. J Pathol. 222:1–15. 2010. View Article : Google Scholar : PubMed/NCBI
14.	Zhou Y, Yan H, Guo M, et al: Reactive oxygen species in vascular formation and development. Oxid Med Cell Longev. 2013:3749632013. View Article : Google Scholar : PubMed/NCBI
15.	Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
16.	Kohno K, Uchiumi T, Niina I, et al: Transcription factors and drug resistance. Eur J Cancer. 41:2577–2586. 2005. View Article : Google Scholar
17.	Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar
18.	Cirri P and Chiarugi P: Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31:195–208. 2012. View Article : Google Scholar : PubMed/NCBI
19.	Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature. 432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
20.	Karnoub AE, Dash AB, Vo AP, et al: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
21.	Mishra PJ, Mishra PJ, Humeniuk R, et al: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68:4331–4339. 2008. View Article : Google Scholar : PubMed/NCBI
22.	Quante M, Tu SP, Tomita H, et al: Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 19:257–272. 2011. View Article : Google Scholar : PubMed/NCBI
23.	Liu S, Ginestier C, Ou SJ, et al: Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 71:614–624. 2011. View Article : Google Scholar : PubMed/NCBI
24.	Cabarcas SM, Mathews LA and Farrar WL: The cancer stem cell niche - there goes the neighborhood? Int J Cancer. 129:2315–2327. 2011. View Article : Google Scholar : PubMed/NCBI
25.	Yasuniwa Y, Izumi H, Wang KY, et al: Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway. PLoS One. 5:e153302010. View Article : Google Scholar : PubMed/NCBI
26.	Fodde R and Brabletz T: Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 19:150–158. 2007. View Article : Google Scholar : PubMed/NCBI
27.	Pagès F, Galon J, Dieu-Nosjean MC, et al: Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 29:1093–1102. 2010.PubMed/NCBI
28.	Mantovani A, Germano G, Marchesi F, et al: Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur J Immunol. 41:2522–2525. 2011. View Article : Google Scholar : PubMed/NCBI
29.	Bateman A: Growing a tumor stroma: a role for granulin and the bone marrow. J Clin Invest. 121:516–519. 2011. View Article : Google Scholar : PubMed/NCBI
30.	Bohring A, Stamm T, Spaich C, et al: WNT10A mutations are a frequent cause of a broad spectrum of ectodermal dysplasias with sex-biased manifestation pattern in heterozygotes. Am J Hum Genet. 85:97–105. 2009. View Article : Google Scholar : PubMed/NCBI
31.	Russell SB, Russell JD, Trupin KM, et al: Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol. 130:2489–2496. 2010. View Article : Google Scholar : PubMed/NCBI
32.	Schäfer M and Werner S: Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 9:628–638. 2008.PubMed/NCBI
33.	Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester L and Reiter RJ: Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem. 17:4462–4481. 2010. View Article : Google Scholar : PubMed/NCBI
34.	Torigoe T, Izumi H, Ishiguchi H, et al: Cisplatin resistance and transcription factors. Curr Med Chem Anticancer Agents. 5:15–27. 2005. View Article : Google Scholar : PubMed/NCBI
35.	Tanabe M, Izumi H, Ise T, et al: Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines. Cancer Res. 63:8592–8595. 2003.PubMed/NCBI
36.	Igarashi T, Izumi H, Uchiumi T, et al: Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene. 26:4749–4760. 2007. View Article : Google Scholar : PubMed/NCBI
37.	Miyamoto N, Izumi H, Miyamoto R, et al: Transcriptional regulation of activating transcription factor 4 under oxidative stress in retinal pigment epithelial ARPE-19/HPV-16 cells. Invest Ophthalmol Vis Sci. 52:1226–1234. 2011. View Article : Google Scholar
38.	Miyamoto N, Izumi H, Noguchi T, et al: Tip60 is regulated by circadian transcription factor clock and is involved in cisplatin resistance. J Biol Chem. 283:18218–18226. 2008. View Article : Google Scholar : PubMed/NCBI
39.	Lévi F, Okyar A, Dulong S, Innominato PF and Clairambault J: Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol. 50:377–421. 2010.
40.	Sun Y, Campisi J, Higano C, et al: Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med. 18:1359–1368. 2012. View Article : Google Scholar : PubMed/NCBI
41.	Guo B, Chatterjee S, Li L, et al: The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway. FASEB J. 26:3453–3463. 2012. View Article : Google Scholar : PubMed/NCBI